Cancer is a group of diseases driven by inherently nanostructural problems. As such, there are obvious benefits to treatments employing nanoscale structures and processes. Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Read our Editorial to learn more
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
Basic, translational and clinical research
Special article collections
Cancer Nanotechnology publishes special article collections on specific topics. Be sure to take a look at the list of collections we have so far by clicking the link above.
We welcome further submissions to these collections.
Alternatively, maybe you have a suggestion for a special collection of your own that you would like to edit. We'd love to hear from you if so!
Courtesy of Andrey Solov'yov
Featured collection — Multiscale Modelling for Cancer Radiotherapies: from X-rays to ions
Andrey Solov'yov and Eugene Surdutovich present this new collection, which provides a platform for scholars and practitioners in disciplines such as physics, chemistry, biology, and medical science, to share and exchange their research, knowledge, and insights related to the scientific base of assessment of cell inactivation in the course of radiation therapy of different modalities from x-rays to ions.
Articles
-
-
Doxorubicin-loaded hollow gold nanospheres for dual photothermal ablation and chemoembolization therapy
-
Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI
-
Reducing the effective dose of cisplatin using gold nanoparticles as carriers
-
Preferential drug delivery to tumor cells than normal cells using a tunable niosome–chitosan double package nanodelivery system: a novel in vitro model
-
Particle therapy and nanomedicine: state of art and research perspectives
-
Biological mechanisms of gold nanoparticle radiosensitization
-
Cisplatin-loaded hollow gold nanoparticles for laser-triggered release
-
Gold nanoparticles for cancer radiotherapy: a review
-
Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment
Stay up to date
Do you want to stay up to date on the latest from Cancer Nanotechnology? Sign up for article alerts and news from this journal in order to receive updates for recently published articles, as well as news about Cancer Nanotechnology and BMC.
Follow
2018 Journal Metrics
-
Speed
77 days to first decision for reviewed manuscripts only
67 days to first decision for all manuscripts
120 days from submission to acceptance
17 days from acceptance to publicationCitation Impact
4.700 - 2-year Impact Factor
9.5 - CiteScore
1.373 - Source Normalized Impact per Paper (SNIP)
1.299 - SCImago Journal Rank (SJR)Usage
116,661 downloads
41 Altmetric mentions
- ISSN: 1868-6966 (electronic)
- ISSN: 1868-6958 (print)
